Epsilon Healthcare Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HDRPF research report →
Companyepsilonhealthcare.com.au
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021.
- CEO
- Peter Giannopoulos
- IPO
- 2018
- HQ
- Sydney, NSW, AU
Price Chart
Valuation
- Market Cap
- $544.75K
- P/E
- -6.24
- P/S
- 0.87
- P/B
- 2.67
- EV/EBITDA
- -11.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.28%
- Op Margin
- -25.31%
- Net Margin
- -13.61%
- ROE
- 404.65%
- ROIC
- -9.79%
Growth & Income
- Revenue
- $9.39M · 67.67%
- Net Income
- $-2,049,851 · -2.06%
- EPS
- $-0.01 · 0.00%
- Op Income
- $-2,216,516
- FCF YoY
- 5.94%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.70
- Avg Volume
- 4.26K
Get TickerSpark's AI analysis on HDRPF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HDRPF Coverage
We haven't published any research on HDRPF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HDRPF Report →